PTAB
Advanced fields
80 decisions · 525msnewest first
  • PTAB · Jan 4, 2023 · IPR2022-00182 · APJ Steven M Amundson · IPR · Rehearing

    Denied Patent Owner’s rehearing request; the Board found no abuse of discretion in instituting IPR of claims 1, 24, and 25 on the stated § 103 grounds.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “II. STANDARD OF REVIEW “The burden of showing a decision should be modified lies with the party challenging the decision.” 37 C.F.R. § 42.71(d) (2022). In a rehearing request, the party challenging the decision “must specifically identify” (1) “all matters the party believes the Board misapprehended or overlooked” and (2) “the place where each matter was previously addressed” in an earlier submission. Id.; see Consolidated Trial Practice Guide at 90.3 “A rehearing request is not an opportunity for the requesting party to reargue its case or merely to express disagreement with the underlying decision.” MicroSurgical Tech., Inc. v. Regents of Univ. of Colo., PGR2021-00026, Paper 14 at 2 (PTAB Aug. 12, 2021). “Nor is it an opportunity for the moving party to present new arguments that were not in its original submissions.” Id.” slip op. at 3

    • Obviousness (§103) › Objective indicia / secondary considerations › CopyingObjective indicia no nexusDecided for petitioner

      “Patent Owner does not explain why issue preclusion permits the Board to hold the district court’s finding that Cisco “copied software functionality from the [infringed] patents” against Petitioner. See Prelim. Resp. 16, 54–56; Req. Reh’g 3, 14–15. Issue preclusion “is appropriate only if”: (1) “the issue is identical to one decided in the first action”; (2) “the issue was actually litigated in the first action”; (3) “resolution of the issue was essential to a final judgment in the first action”; and (4) the party defending against preclusion “had a full and fair opportunity to litigate the issue in the first action.” SynQor, Inc. v. Vicor Corp., 988 F.3d 1341, 1353 (Fed. Cir. 2021). Patent Owner does not address any of these requirements for issue preclusion. See Prelim. Resp. 16, 54–56; Req. Reh’g 3, 14–15.” slip op. at 13

    • Obviousness (§103) › Motivation to combine / reasonable expectation of successNot reached

      “Regarding the policy’s whitelist processing, if the security device determines that a newly received packet with encrypted data is correlated to the hostname corresponding to the whitelisted destination domain, the security device filters the packet by forwarding it to the remote server with the whitelisted destination domain. See Ex. 1004, 7:52–59, 16:36–42; Ex. 1003 ¶ 90; see also Ex. 1004, 6:1–11. Filtering the newly received packet with encrypted data by forwarding it to the remote server with the whitelisted destination domain occurs “without having to decrypt the encrypted secure tunnel session traffic.” Ex. 1004, 5:24–27, 5:35–42, 7:1–9, 11:7–19; see Ex. 1003 ¶¶ 94, 113. Further, filtering the newly received packet with encrypted data by forwarding it to the remote server with the whitelisted destination domain results from applying a packet-filtering rule (a whitelisted destination domain) to the packet. Hence, we disagree with Patent Owner that Buruganahalli’s security devices process whitelisted packets by “forward[ing] the entire encrypted stream without . . . filtering encrypted packets.” See Req. Reh’g 10. We also disagree with Patent Owner that “encrypted packets in whitelisted sessions” are (1) “forwarded without applying any packet-filtering rules” and (2) “allowed uninspected.” See id. at 11 n.1, 13. Regarding the policy’s blacklist processing, if the security device determines that a newly received packet with encrypted data is correlated to the hostname corresponding to the blacklisted destination domain, the security device either blocks the packet (as Patent Owner contends) or filters the packet by forwarding it to a decryption engine. See Ex. 1004, 7:60–67, 9:61–67, 14:33–36, 16:43–48; Ex. 1003 ¶¶ 90–91, 94, 97, 108, 118, 127, 137; Req. Reh’g 10–11, 13. Filtering the newly received packet with encrypted data by forwarding it to a decryption engine occurs “without having to decrypt the encrypted secure tunnel session traffic.” Ex. 1004, 5:24–27, 5:35–42, 7:1–9, 11:7–19; see Ex. 1003 ¶¶ 94, 113, 135. Further, filtering the newly received packet with encrypted data by forwarding it to a decryption engine results from applying a packet-filtering rule (a blacklisted destination domain) to the packet and corresponds to limitation [1.g] and the similar limitations in claims 24 and 25. See Ex. 1003 ¶¶ 109, 134–135. The Institution Decision explained how Buruganahalli’s security devices may filter packets comprising unencrypted data and packets comprising encrypted data according to claims 1, 24, and 25 by applying a whitelist/blacklist policy to the packets. See, e.g., Inst. Dec. 57–60, 66–67, 69–71. As the Institution Decision explained and as discussed above, “for each session packets comprising unencrypted data and packets comprising encrypted data are correlated and filtered based on the hostname (destination domain) extracted from the handshake traffic, and then the correlated and filtered packets are processed separately from packets destined for other domains.” See Inst. Dec. 69–70; Ex. 1003 ¶¶ 109, 120–121, 133–135; Ex. 1004, 7:39–67, 8:55–60, 11:47–51, 14:21–33, 14:50–55, 16:32–48. Buruganahalli discloses additional filtering after forwarding a newly received packet with encrypted data to a decryption engine, e.g., as occurs in Buruganahalli’s Figure 3B embodiment. See, e.g., Ex. 1004, 6:17–22, 9:67–10:4, 12:4–64, Fig. 3B. But claims 1, 24, and 25 use the transitional term “comprising.” Ex. 1001, 25:14, 28:59, 29:29–30. Hence, the claims do not “exclude unrecited elements,” such as additional filtering after forwarding a newly received packet with encrypted data to a decryption engine. See Regeneron Pharm., Inc. v. Merus N.V., 864 F.3d 1343, 1352 (Fed. Cir. 2017) (citing Manual of Patent Examining Procedure § 2111.03).” slip op. at 8

    § 103 obviousness
    Patents in suitUS 9,917,856
  • PTAB · Jul 7, 2021 · IPR2020-01466 · APJ Melissa A Haapala · IPR · Rehearing

    The Board denied rehearing and left in place the denial of institution on claims 1–12 because petitioner showed no overlooked matter or abuse of discretion.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “On rehearing, the burden of showing that the Decision should be modified lies with Petitioner, the party challenging the Decision. See 37 C.F.R. § 42.71(d). “The request must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, a reply, or a sur-reply.” Id. “When rehearing a decision on petition, a panel will review the decision for an abuse of discretion.” 37 C.F.R. § 42.71(c).” slip op. at 2

    • PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)Institution denied meritsInstitution denied

      “establish Hettstedt discloses the “reconfiguring each remote radio unit.” See Dec. 15. We disagree that we overlooked any arguments presented in the Petition with respect to this limitation. In its analysis of the “reconfiguring each remote radio unit” limitation in the Petition, Petitioner relied on Hettstedt’s disclosure that the CMU controls the frequency allocation of each carrier to the remote radio heads “by changing the MAC address of a specific carrier packet to correspond no longer to a first remote radio head, but instead be addressed to a different radio head in a high traffic area.” See Pet. 22 (citing Ex. 1005, 5:10–11; 3:8–16; 4:35–39). Our Decision expressly addressed Petitioner’s arguments and evidence: After reviewing Petitioner’s analysis and supporting evidence, and Patent Owner’s response, we determine Petitioner fails to establish Hettstedt discloses “reconfiguring each remote radio unit” as we construe the claim (changing the configuration of each remote radio unit). Petitioner relies on Hettstedt’s disclosure that the CMU controls allocation of each carrier by changing the MAC addresses of carrier packets to disclose the recited “reconfiguring.” See Pet. 22. However, while changing the MAC addresses of carrier packets may result in an increase or decrease of the number of carriers assigned to a radio head by the CMU when routing traffic, it does not reconfigure (change) the configuration of the remote radio head itself. As we noted in our analysis of the claim construction of this term, the plain language of the claim requires that the remote radio head itself be reconfigured. Petitioner’s analysis does not address how Hettstedt discloses reconfiguring the remote radio unit itself.” slip op. at 3

    • Claim Construction › Intrinsic evidence (Phillips canons) › Plain and ordinary meaning to a POSITATerm construed patent owner constructionDecided for patent owner

      “We are unpersuaded that we misconstrued the phrase “reconfiguring each remote radio unit by.” Petitioner’s proposed claim construction in the Rehearing Request does not give patentable weight to the claimed “reconfiguring each remote radio unit.” Although we agree with Petitioner that claim 1 requires limitations [b] and [c] (i.e., “determining a load percentage” and “increasing or decreasing the number of carriers”), we disagree with Petitioner that the term “by” before limitations [b] and [c] would require what comes before “by” to have no patentable weight. Rather, as stated in our Decision: we adopt the district court’s construction and construe “reconfiguring each remote radio unit” to be “changing the configuration of each remote unit.” We additionally note that the claim term requires that it is the remote radio unit itself that is changed because the “remote radio unit” is the direct object of the verb “reconfiguring.” This is consistent with the specification of the ’338 patent, which describes reconfiguring the RRUs themselves. Dec. 9–10 (citing Ex. 1001, 4:1–13, 7:16–31, 8:8–21, 8:48–55, 11:28–39).” slip op. at 7

    • Strike new argumentNew argument disregardedDecided for patent owner

      “In its rehearing request, Petitioner now newly argues that we overlooked Hettstedt’s disclosure that remote radio heads are channel-selective in the uplink (i.e., column 5, lines 6–8 of Hettstedt). But Petitioner’s new analysis and explanation that Hettstedt’s teaches “reconfiguring each remote radio unit head” because its radio units are channel selective in the uplink was not presented in the Petition, and we could not have overlooked arguments or evidence not before us.2 See 37 C.F.R. 42.71(d). A petition must include “a detailed explanation of the significance of the evidence.” 37 C.F.R. § 42.22(a)(2). We are not persuaded of any error in our Decision that Petitioner failed to demonstrate a reasonable likelihood of prevailing in establishing that claim 1 is anticipated by Hettstedt. See Dec. 13–15. 2 We acknowledge Petitioner’s reliance on Hettstedt’s column 5, lines 6–8 on page 21 of the Petition; however, the Petition relied on this portion of Hettstedt for Element F of claim 1 (“configuring each remote radio unit to receive or transmit a respective subset of the plurality of carriers, each respective subset of the plurality of carriers including a number of carriers”), not for Element G of claim 1 (“reconfiguring each remote radio unit by . . .”). See Pet. 21. Petitioner’s Rehearing Request also points to reliance on Hettstedt’s column 5, lines 6–8 on page 10 of the Petition and in paragraphs of Dr. Acampora’s testimony (see Req. Reh’g 6–8 (citing Pet. 10; Ex. 1003 ¶¶ 46–54)), however (i) page 10 of the Petition and paragraphs 46–52 of Dr. Acampora’s testimony are not addressing the “reconfiguring each remote radio unit” limitation, and (ii) while paragraphs 53–54 of Dr. Acampora’s testimony addresses the “reconfiguring each remote radio unit” these paragraphs do not reference Hettstedt’s column 5, lines 6–8. See Pet. 10; Ex. 1003 ¶¶ 46–54.” slip op. at 4

    Claim construction
    Patents in suitUS 8,682,338
  • PTAB · Jan 5, 2021 · IPR2020-00483 · APJ Brian J Mcnamara · IPR · Rehearing

    The Board denied Patent Owner’s rehearing request, leaving institution in place after finding no pertinent matter was overlooked or misapprehended.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “When rehearing a decision on institution, the Board reviews the decision for an abuse of discretion. 37 C.F.R. § 42.71(c). An abuse of discretion may arise if the decision is based on an erroneous interpretation of law, if a factual finding is not supported by substantial evidence, or if an unreasonable judgment is made in weighing relevant factors. Star Fruits S.N.C. v. U.S., 393 F.3d 1277, 1281 (Fed. Cir. 2005); Arnold P’ship v.” slip op. at 2

    • PTAB / AIA Trials › Discretionary denial › §325(d) same art / argumentsDecided for petitioner

      “we do not hold the Petition to recite the exact wording of Advanced Bionics that– “the Office erred in a manner material to the patentability of the challenged claims.” Nevertheless, we reviewed the challenges in the Petition and the prosecution history to assess whether Petitioner had demonstrated material error by the Office. We noted that challenged claim 29 (application claim 50) was allowed after it was amended to include 4 The Petition has been accorded a filing date of February 3, 2020. The decision in Advanced Bionics was issued on February 13, 2020 and designated precedential on March 24, 2020. command keys positioned on the handle. Dec. to Inst. 19; see also Pet. 15‒ 16 (discussing prosecution history and the Examiner’s identification of allowable subject matter). We also found persuasive Petitioner’s arguments that these same features are found in Rosenhan. Id. (referencing Pet. 31‒ 33). As a result, we determined that the Office’s failure to recognize Rosenhan discloses features that prompted the Examiner to allow the claims was an error material to the patentability of the challenged claims. Id. Patent Owner’s Request for Rehearing does not dispute the substance of this analysis. Req. Reh’g. 2–5. Patent Owner’s argument that our approach “bootstraps” reasonable likelihood of success into the analysis of Office error is incorrect. Req. Reh’g. 5. Our analysis of the Office’s error focuses on the features that led the Examiner to allow the claim. Dec. to Inst. 19. That analysis is separate and distinct from our analysis of whether Petitioner demonstrated a reasonable likelihood of success by showing the reference teaches each of the elements of the claim to a person of ordinary skill. Id. at 23–25.” slip op. at 4

    • Other 314aDecided for petitioner

      “Here, as discussed below, the Decision to Institute weighed the factors argued in the Preliminary Response concerning discretionary denial of institution under Section 314(a). Section 314(a) states “the Director may not authorize an inter partes review unless the Director determines the information presented in the petition . . . shows that there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” Although Section 314(a) does not require the Director to institute inter partes review in any particular case (see Oil States Energy Servs., LLC v. Greene’s Energy Grp., 138 S. Ct. 1365, 1371 (2018)), the Decision to Institute concluded that the Petition in this case satisfied the requirements for institution under Section 314(a) and that the circumstances of this case do not support exercising discretion to deny Petitioner its ability under the statute to obtain inter partes review.” slip op. at 8

    Discretionary denial
    Patents in suitUS 9,503,627
  • PTAB · May 29, 2020 · IPR2019-01413 · APJ Karl D Easthom · IPR · Rehearing

    The Board denied Rovi Guides’ rehearing request, leaving institution of inter partes review of claims 1–22 in place because the request showed no matters misapprehended or overlooked.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “institute an inter partes review, the Board reviews its decision for an abuse of discretion. 37 C.F.R. § 42.71(c). The party requesting rehearing bears the burden of showing that the decision should be modified, and “[t]he request must specifically identify all matters the party believes the Board misapprehended or overlooked.” 37 C.F.R. § 42.71(d)” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), did not warrant terminating or staying this case. Dec. 26–27. Specifically, we explained that, according to Arthrex, “no constitutional infirmity [exists] in an institution decision.” Id. at 27 (quoting Arthrex, 941 F.3d at 1340) (alteration in Decision). We also explained that we generally do not stay cases pending an appeal to the Federal Circuit or the Supreme Court. Id.” slip op. at 2

    None
    Patents in suitUS 9,232,254
  • PTAB · Mar 25, 2020 · IPR2019-00292 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests, leaving in place its denial of authorization to seek a stay or termination based on Arthrex.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    None
    Patents in suitUS 7,937,394
  • PTAB · Mar 25, 2020 · IPR2019-00281 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests challenging the denial of authorization to seek a stay or termination based on Arthrex and the APA.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 9,621,956
  • PTAB · Mar 25, 2020 · IPR2019-00239 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests seeking authorization to move to stay or terminate the proceedings based on Arthrex and the APA.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 7,779,011
  • PTAB · Mar 25, 2020 · IPR2019-00555 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests seeking authorization to move to stay or terminate the proceedings based on Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 9,668,014
  • PTAB · Mar 25, 2020 · IPR2019-00290 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s rehearing requests challenging denial of authorization to seek a stay or termination based on Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    None
    Patents in suitUS 7,937,394
  • PTAB · Mar 25, 2020 · IPR2019-00237 · APJ William M Fink · IPR · Rehearing

    The Board denied Patent Owner’s requests for rehearing of its denials of authorization to seek a stay or termination, rejecting the Arthrex and APA arguments.

    RulingsRehearing decision
    • RehearingRehearing, deniedDenied

      “The party requesting rehearing has the burden to show that the decision should be modified. 37 C.F.R. § 42.71(d). Additionally, the request for rehearing “must specifically identify all matters the party believes the Board misapprehended or overlooked, and the place where each matter was previously addressed in a motion, an opposition, or a reply.” Id.” slip op. at 2

    • PTAB / AIA Trials › Constitutional / APA (Arthrex, Oil States, due process)Decided for petitioner

      “(1) because the Federal Circuit’s mandate has not issued in Arthrex, the Administrative Patent Judges presiding over the instant proceedings remain unconstitutionally appointed and, therefore, the instant proceedings should be stayed (Reh’g Req. 6–8); (2) the proceedings should be stayed because the Arthrex remedy does not go far enough and violates the Administrative Procedure Act (APA) (id. at 9–13 (citing, e.g., Polaris Innovations Ltd. v. Kingston Tech. Co., No. 18-1768, Dkt. No. 90 at 2 (Fed. Cir. Nov. 8, 2019))); and (3) intervention from Congress and agency rulemaking may be necessary to remedy the defect identified in Arthrex, so termination of each of the instant proceedings is warranted (id. at 13–15). Patent Owner’s arguments have been addressed in our denials.6 See, e.g., IPR2019-00224, Paper 28 at 2 (PTAB Jan. 14, 2020) (quoting Arthrex, 941 F.3d at 1337 (“This as-applied severance . . . cures the constitutional violation”)); IPR2019-00224, Paper 39 at 4 (PTAB Feb. 18, 2020) (“[I]t is unclear how the issuance of the mandate in Arthrex would address the alleged APA defect.”). For these reasons, we also disagree with Patent Owner’s argument 6 In any event, the issuance of the mandate in Image Processing Techs. LLC v. Samsung Electronics Co. moots Patent Owner’s argument that Board judges are unconstitutionally appointed until the mandate in Arthrex issues. See Image Processing Techs. LLC v. Samsung Electronics Co., No. 2018- 2156 (Fed. Cir. Mar. 9, 2020), ECF No. 78; Mandate, Image Processing Techs. LLC v. Samsung Elecs. Co., Nos. 2019-1408, 2019-1485 (Fed. Cir. Mar. 9, 2020), ECF No. 75 (relying on Arthrex). Furthermore, in Arthrex, the Federal Circuit denied the petitions for panel rehearing and the petitions for rehearing en banc. Arthrex, Inc. v. Smith & Nephew, Inc., No. 2018-2140 (Fed. Cir. Mar. 23, 2020), ECF No. 115. that denying Patent Owner the opportunity for briefing “itself violates the [APA] because the denial lacks a reasoned basis.” Reh’g Req. 1. Accordingly, we deny Patent Owner’s Requests for Rehearing.” slip op. at 3

    None
    Patents in suitUS 7,779,011
Page 1 of 8
← Previous12345…Next →

Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.